| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/02/2003 | EP0702518B1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 04/02/2003 | EP0610427B1 Tgf-beta type iii receptor, cdna encoding it and uses therefor |
| 04/02/2003 | EP0587800B1 Immunomodulatory azaspiranes |
| 04/02/2003 | CN1407992A Process for producing functional silk fibroin and utilization of the same |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407987A Hexahydrofuro'2,3-Blfuran-3-yl-N-´¢ø3'(1,3-benzodioxol-5-ylsulfonyl)(isobutyl) Aminol-1-benzyl-2-hydroxypropyl´¢Øcarbamate as retroviral protease inhibitor |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407984A 1,8-naphthyridin-2 (1H)-one derivatives |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/02/2003 | CN1407982A Serotonergic benzofurans |
| 04/02/2003 | CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 04/02/2003 | CN1407973A Butyne diol derivatives |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1407903A Concomitant drugs for treating glaucoma |
| 04/02/2003 | CN1407900A Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (MPIF-1) |
| 04/02/2003 | CN1407899A Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 04/02/2003 | CN1407893A Triazinone compounds for treating diseases resulting from infretation with parasitic protozoans |
| 04/02/2003 | CN1407892A Intermittent claudication remedies |
| 04/02/2003 | CN1407891A Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 04/02/2003 | CN1407885A Histamine H2 antagonist effervescent composition |
| 04/02/2003 | CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
| 04/02/2003 | CN1406630A Composite enzyme reacting liquid |
| 04/02/2003 | CN1406623A Levulose absorption retardant, compound, food and levulose absorption repressor |
| 04/02/2003 | CN1104439C Phenyl substituted 4-azasteroidal fluorine derivatives, preparation thereof and pharmaceutical compositions containing them |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/02/2003 | CN1104257C Oesteoblast growth stimulating composition containing PDGF and vitamin D |
| 04/01/2003 | WO2002029054A1 Novel protein, process for producing the same and use thereof |
| 04/01/2003 | US6541672 Showing anti-bacterial, antioxidant, and anti-inflammatory activities that enable them to be used for drugs |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541661 Inhibitors of histone deacetylase |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541629 Enzyme inhibitors |
| 04/01/2003 | US6541518 Preventing pathogens in blood plasma and for enhancing the production of cryoprecipitate from plasma by adding a low molecular weight carboxylic acid or salt to the plasma, preferably trisodium citrate |
| 04/01/2003 | US6541508 Water solubility; prodrug containing polyether oligomer |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6541502 Treatment of disorders associated with dopamine dysregulation such as schizophrenia |
| 04/01/2003 | US6541499 Benzimidazole derivatives; e.g., 5-hydroxy-1-(3-methoxy-4-((1,2,4-triazol-1-yl)-methyl)benzyl) -2-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-benzimidazole |
| 04/01/2003 | US6541496 Inhibitors of IMPDH enzyme |
| 04/01/2003 | US6541492 Thiazole derivatives as PPAR gamma ligands |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541488 Compositions for treating arterial thrombosis and a factor Xa inhibitor |
| 04/01/2003 | US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. |
| 04/01/2003 | US6541485 Urea substituted imidazoquinolines |
| 04/01/2003 | US6541484 Central nervous system disorders; psychological disorders |
| 04/01/2003 | US6541482 Autoimmune disease |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541476 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541469 CRF receptor antagonists and methods relating thereto |
| 04/01/2003 | US6541468 Treating Alzheimer's disease by inhibiting in a subject hyperphosphoralation characteristic of Alzheimer's disease by a kinase the compound |
| 04/01/2003 | US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
| 04/01/2003 | US6541457 Mammalian IAP gene family, primers, probes and detection methods |
| 04/01/2003 | US6541255 Engraftable human neural stem cells |
| 04/01/2003 | US6541026 Nutritional composition, methods of producing said composition and methods of using said composition |
| 04/01/2003 | US6541025 Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| 04/01/2003 | US6541015 Water soluble prodrug with a biologically active agent link trapped in a hydrogel and controllably released by diffusion |
| 04/01/2003 | US6541003 An immunizing formulation comprising a plasmid encoding an attenuated, doxycycline-inducible proviral molecular clone of the human immunodeficiency virus type 1, and a pharmaceutical carrier |
| 04/01/2003 | US6540978 Inhibitors of the bitter taste response |
| 04/01/2003 | CA2424777A1 Novel protein, process for producing the same and use thereof |
| 04/01/2003 | CA2163539C N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes |
| 03/31/2003 | WO2002030425A1 Preventives and remedies for complications of diabetes |
| 03/31/2003 | CA2424060A1 Preventives and remedies for complications of diabetes |
| 03/28/2003 | WO2002026745A1 Thienopyrimidine compounds and their salts and process for preparation of both |
| 03/28/2003 | CA2423981A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
| 03/28/2003 | CA2405342A1 Methods of treatment and kits comprising a growth hormone secretagogue |
| 03/27/2003 | WO2003029411A2 Novel cyclooxygenase variants and methods of use |
| 03/27/2003 | WO2003025542A2 Immune response associated proteins |
| 03/27/2003 | WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 03/27/2003 | WO2003025193A1 Plant enzymes for bioconversion |
| 03/27/2003 | WO2003025168A1 Novel protein and dna thereof |
| 03/27/2003 | WO2003025129A2 Neurotransmission-associated proteins |
| 03/27/2003 | WO2003025121A2 Igf-binding protein-derived peptide or small molecule |
| 03/27/2003 | WO2003025119A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 03/27/2003 | WO2003025019A1 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | WO2003024997A1 Telomerase inhibitory peptides and uses thereof |
| 03/27/2003 | WO2003024976A2 Tricyclic indole derivatives as 5-ht ligands |
| 03/27/2003 | WO2003024973A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024971A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 03/27/2003 | WO2003024970A1 Compounds which inhibit the release of inflammatory cytokines |
| 03/27/2003 | WO2003024967A2 Indolizines as kinase protein inhibitors |
| 03/27/2003 | WO2003024966A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 03/27/2003 | WO2003024965A2 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 03/27/2003 | WO2003024958A2 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
| 03/27/2003 | WO2003024956A1 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 03/27/2003 | WO2003024952A1 Bioprecursors for percutaneous application |
| 03/27/2003 | WO2003024950A1 Coumarin derivative |
| 03/27/2003 | WO2003024949A1 Dna-pk inhibitors |
| 03/27/2003 | WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 03/27/2003 | WO2003024942A1 Thiazolidine derivative and medicinal use thereof |
| 03/27/2003 | WO2003024941A1 Naphthalene compounds and use thereof as drugs |
| 03/27/2003 | WO2003024936A1 Substituted pyrazolo compounds for the treatment of inflammation |
| 03/27/2003 | WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 03/27/2003 | WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 03/27/2003 | WO2003024928A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/27/2003 | WO2003024926A2 Methods and compositions of novel triazine compounds |